Predictive Oncology Return on Tangible Equity 2010-2024 | POAI

Current and historical return on tangible equity values for Predictive Oncology (POAI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Predictive Oncology Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $-0.01B $0.00B -288.89%
2024-06-30 $-0.01B $0.00B -192.59%
2024-03-31 $-0.01B $0.00B -151.35%
2023-12-31 $-0.01B $0.01B -101.96%
2023-09-30 $-0.02B $0.01B -110.77%
2023-06-30 $-0.02B $0.01B -95.00%
2023-03-31 $-0.03B $0.02B -104.17%
2022-12-31 $-0.03B $0.02B -96.15%
2022-09-30 $-0.03B $0.03B -90.09%
2022-06-30 $-0.03B $0.03B -80.00%
2022-03-31 $-0.02B $0.03B -51.70%
2021-12-31 $-0.02B $0.03B -53.33%
2021-09-30 $-0.02B $0.05B -78.63%
2021-06-30 $-0.03B $0.05B -147.06%
2021-03-31 $-0.03B $0.03B -800.00%
2020-12-31 $-0.03B $-0.00B 432.00%
2020-09-30 $-0.03B $-0.00B 413.79%
2020-06-30 $-0.03B $-0.01B 327.27%
2020-03-31 $-0.02B $-0.01B 283.87%
2019-12-31 $-0.02B $-0.01B 347.83%
2019-09-30 $-0.01B $-0.01B 225.00%
2019-06-30 $-0.01B $-0.01B 533.33%
2019-03-31 $-0.01B $-0.00B -1466.67%
2018-12-31 $-0.01B $-0.00B -444.44%
2018-09-30 $-0.01B $0.00B -246.15%
2018-06-30 $-0.01B $0.00B -184.62%
2018-03-31 $-0.01B $0.01B -215.38%
2017-12-31 $-0.01B $0.00B -200.00%
2017-09-30 $-0.01B $0.00B -240.00%
2017-06-30 $-0.01B $0.00B -300.00%
2017-03-31 $-0.01B $0.00B -400.00%
2016-12-31 $-0.01B $0.00B -700.00%
2016-09-30 $-0.01B $0.00B -457.14%
2016-06-30 $-0.01B $0.00B -246.15%
2016-03-31 $-0.01B $0.00B -400.00%
2015-12-31 $-0.00B $0.00B 800.00%
2015-09-30 $-0.00B $0.01B 133.33%
2015-06-30 $-0.00B $-0.01B 72.73%
2015-03-31 $-0.01B $-0.01B 105.26%
2014-12-31 $-0.01B $-0.01B 186.67%
2014-09-30 $-0.01B $-0.00B 233.33%
2014-06-30 $-0.01B $-0.00B 444.44%
2014-03-31 $-0.01B $-0.00B 360.00%
2013-12-31 $-0.01B $-0.00B 327.27%
2013-09-30 $-0.01B $-0.00B 327.27%
2013-06-30 $-0.01B $-0.00B 266.67%
2013-03-31 $-0.01B $-0.00B 360.00%
2012-12-31 $-0.01B $-0.00B 320.00%
2012-09-30 $-0.01B $-0.00B 360.00%
2012-06-30 $-0.01B $-0.00B 254.55%
2012-03-31 $-0.01B $-0.00B 166.67%
2011-12-31 $-0.00B $-0.00B 145.45%
2011-09-30 $-0.00B $-0.00B 40.00%
2011-06-30 $0.00B $-0.00B 0.00%
2011-03-31 $0.00B $-0.00B 0.00%
2010-12-31 $-0.00B $-0.00B 44.44%
2010-09-30 $-0.00B $-0.00B 44.44%
2010-06-30 $-0.00B $-0.00B 88.89%
2010-03-31 $-0.00B $-0.00B 171.43%
2009-12-31 $-0.00B $-0.00B 300.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.005B $0.002B
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $9.226B 0.00
Inspire Medical Systems (INSP) United States $5.656B 176.38
Hims & Hers Health (HIMS) United States $5.534B 140.72
Enovis (ENOV) United States $2.608B 17.68
Privia Health (PRVA) United States $2.587B 215.60
IRhythm Technologies (IRTC) United States $2.316B 0.00
Azenta (AZTA) United States $2.209B 110.15
Omnicell (OMCL) United States $2.116B 69.23
10x Genomics (TXG) United States $1.732B 0.00
Clover Health Investments (CLOV) United States $1.689B 0.00
Schrodinger (SDGR) United States $1.518B 0.00
Phreesia (PHR) United States $1.148B 0.00
Butterfly Network (BFLY) United States $0.690B 0.00
Standard BioTools (LAB) United States $0.596B 0.00
Talkspace (TALK) United States $0.583B 0.00
Fulgent Genetics (FLGT) United States $0.547B 0.00
Definitive Healthcare (DH) United States $0.505B 87.40
Health Catalyst (HCAT) United States $0.495B 0.00
Pulmonx (LUNG) United States $0.268B 0.00
TruBridge (TBRG) United States $0.247B 71.91
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
American Well (AMWL) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.112B 0.00
P3 Health Partners (PIII) United States $0.076B 0.00
HeartBeam (BEAT) United States $0.074B 0.00
111 (YI) China $0.052B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Outset Medical (OM) United States $0.044B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
Zepp Health (ZEPP) China $0.037B 0.00
Movano (MOVE) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
MSP Recovery (LIFW) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00